NM_018557.3:c.206-7845G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018557.3(LRP1B):c.206-7845G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 151,946 control chromosomes in the GnomAD database, including 14,892 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.42   (  14892   hom.,  cov: 31) 
Consequence
 LRP1B
NM_018557.3 intron
NM_018557.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -3.29  
Publications
9 publications found 
Genes affected
 LRP1B  (HGNC:6693):  (LDL receptor related protein 1B) This gene encodes a member of the low density lipoprotein (LDL) receptor family. These receptors play a wide variety of roles in normal cell function and development due to their interactions with multiple ligands. Disruption of this gene has been reported in several types of cancer. [provided by RefSeq, Jun 2016] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.689  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| LRP1B | NM_018557.3  | c.206-7845G>A | intron_variant | Intron 2 of 90 | ENST00000389484.8 | NP_061027.2 | ||
| LRP1B | XM_017004341.2  | c.-185-7845G>A | intron_variant | Intron 2 of 90 | XP_016859830.1 | |||
| LRP1B | XM_047444771.1  | c.317-7845G>A | intron_variant | Intron 2 of 76 | XP_047300727.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.423  AC: 64251AN: 151828Hom.:  14888  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
64251
AN: 
151828
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.423  AC: 64279AN: 151946Hom.:  14892  Cov.: 31 AF XY:  0.430  AC XY: 31943AN XY: 74280 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
64279
AN: 
151946
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
31943
AN XY: 
74280
show subpopulations 
African (AFR) 
 AF: 
AC: 
9759
AN: 
41456
American (AMR) 
 AF: 
AC: 
7394
AN: 
15256
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1778
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3657
AN: 
5164
South Asian (SAS) 
 AF: 
AC: 
3117
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
4819
AN: 
10548
Middle Eastern (MID) 
 AF: 
AC: 
164
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
32313
AN: 
67930
Other (OTH) 
 AF: 
AC: 
943
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1798 
 3597 
 5395 
 7194 
 8992 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 618 
 1236 
 1854 
 2472 
 3090 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2184
AN: 
3476
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.